Legislation


S 2535 (see companion bill H 7706) – Rhode Island

Status: Inactive / Dead
Year Introduced: 2018
Link: http://webserver.rilin.state.ri.us/BillText18/SenateText18/S2535.pdf

THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT: Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment